A 34-year-old Japanese man diagnosed as having cateye syndrome (CES) with isolated idiopathic hypogonadotropic hypogonadism (IHH) was treated at our university. He showed preauricular pits/tags, downward slanting palpebral fissures, ocular hypertelorism, and strabismus. However, ocular coloboma and anal atresia, major characteristic features of CES, were negative. Chromosomal analysis revealed malformation in chromosome 22 and eunuchoid features and a low grade development of secondary sexual characteristics were also evident. Endocrinological examinations revealed that this patient was in a state of isolated IHH. Although CES with IHH is extremely rare, endocrine disorders should be given due attention. 
Introduction
In 1965, cat-eye syndrome (CES) was first reported by Schachenmann et al on the association of iris coloboma and anal atresia with a small extra chromosome (1) . CES shows characteristic of ocular coloboma, preauricular anomalies, heart defect, anal atresia, preauricular pits or tags, and, in some cases, mental retardation (2) . Using the fluorescence in situ hybridization (FISH) technique, the diagnosis is made by the presence of an extra marker chromosome derived from chromosome 22. The marker is usually bisatellite and dicentric [idic (22) (pter q11.2)], resulting in tetrasomy of the p arm and a part of 22q11.2 (2) .
Isolated idiopathic hypogonadotropic hypogonadism (IHH) is a condition in which isolated gonadal failure occurs in the setting of low gonadotropin and the absence of any pituitary or hypothalamic anatomic cause. The prevalence of IHH was approximately 1 case in 10,000 men in a study of French conscripts (3) and commonly presents partial pubertal development and/or isolated infertility, caused by a deficiency of gonadotropins. IHH can occur independently or be associated with other somatic abnormalities. When associated with anosmia, the condition is referred to as Kallmann syndrome (4).
We report an extremely rare case of CES presenting isolated idiopathic hypogonadotropic hypogonadism.
Case Report
A 34-year-old Japanese man was referred to the outpatient clinic in Hokkaido University Hospital for pain in his right knee joint. An incomplete closure of epiphysial line was found on the X-ray and his bone age was estimated as that of a 16-year-old by the Greulich-Pyle method. To investigate specific facial features and delayed bone age, he was admitted to our hospital. In the past history, he received an operation for cryptorchism of right testis at the age of 5 and had received medication for epilepsy for the age of 12 years old for 2 years.
The patient was 176 cm tall and weighed 62 kg. Blood pressure was 108/52 mmHg. Preauricular pits/tags, downward slanting palpebral fissures, ocular hypertelorism, and strabismus were evident, whereas no iris coloboma and anal atresia were noted. He showed eunuchoid feature (arm span 182 cm) and low grade development of secondary sexual characteristics; he had sparse axially and pubic hair without barba. Smallsmall penis (2.2 cm) and bilateral testicular atrophy (right testis; not palpable, left testicular volume; was 1.5 ml, normal: 15-25 ml) were observed. He had neither, voice change nor experience of erection and ejaculation. His olfaction was normal as were urinalysis and blood chemistry except for ALP and bone ALP (Table 1) . Inflammatory reactions and autoantibodies examined were negative. On endocrinological examinations, thyroid function, growth hormone (GH)-insulin like growth factor (IGF)-1 axis and ACTH-adrenal axis were normal. Serum concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone were undetectable or low (Tables 1,  2 ). On the repetitive gonadotropin releasing hormone (GnRH) tests, gonadotropins showed a gradual increased response (Table 2) . On the HCG loading test, testosterone levels were slight, but showed a significant response (Table 2) . These results indicated that the main lesion of the hypogonadotropic hypogonadism of the patient was in the hypothalamus. Brain MRI showed no abnormality on the hypothalamic and hypophyseal region.
The GTL (Giemsa/Trypsin/Leishman)-banding chromosome analysis of this patient showed a bisatellited marker chromosome (Fig. 1A) . Fluorescence in situ hybridization (FISH) revealed that both normal chromosomes and the extra marker chromosome were hybridized with the long arm of chromosome 22 specific DNA probes (WCP22), indicating that the marker chromosome originated from the long arm of chromosome 22 (Fig. 1B) . Considering his specific features, endocrinological data and radiological and cytogenetic analyses, the patient was diagnosed as CES with isolated IHH.
In an attempt to develop secondary sexual characteristics and to fuse epiphysial line, androgen replacement therapy was started (testosterone enantate 125 mg/month, intramuscularly). Concomitant with the normalization of serum testosterone levels, axillar and pubic hair became apparent and epiphysial fusion was comfirmed.
Discussion
CES is a rare malformation syndrome with a variable pattern of congenital anomalies ( Table 3 ). The following major malformations are indicated: anal atresia, coloboma of the iris, congenital heart malformations, and urogenital malformations. In addition, minor anomalies include preauricular events, hypertelorism, micrognathia, and mental retardation etc. (Table 3 ). Only 41% of CES with a bisatellited marker chromosome 22 show the classical triad of iris coloboma, anal anomalies, and preauricular malformation. In turn, less than 10% of patients with CES present all major clinical signs of CES (5) . Correlation of clinical severity has been found neither with size of the marker chromosome nor with the extent of mosaicism in mosaic CES (6) . The proximal part of the long arm of chromosome 22 (22q11.2) containing both CES and DiGeorge critical region has been recognized as a hot spot for chromosomal rearrangement that lead to altered gene dosage, resulting in genomic disorders characterized by mental retardation and/or congenital malformations. Three such disorders, e.g. cat-eye syndrome (CES), der (22) syndrome and velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS), are associated with four, three and one dose of parts of 22q11, respectively. The critical region for CES lies centromeric to the deletion region of VCFS/DGS, although, in some cases, the extra material in CES extends across the VCFS/DGS region (6). However, those disorders, in general, do not show evidence of hypogonadotropic hypogonadism.
Hypogonadotropic hypogonadism is caused by various miscellaneous conditions (e.g. Langerhans histiocytosis, (7). Despite the genetic heterogeneity, only one gene has been identified for normosmic isolated IHH in humans, the GnRH receptor gene (GNRHR) (8) . GNRHR mutations account for only 40% of recessive cases, suggesting that other genes play a role in the pathogenesis of IHH (9) . In addition to the GNRHR gene, several responsible genes of IHH such as KAL1, DAX-1, PC1, PROP1 have been reported (10) . In 2003, GPR54 and KAL2 genes were identified as a novel gene causing IHH. GPR54 is the gene encoding for orphan G protein-coupled receptor and inactivating mutations of GPR54 were described in the idiopathic form of gonadotropic deficiency (11) . KAL2 gene encodes fibroblast growth factor receptor 1 (FGFR1) protein which associates with anosmin-1 encoded by KAL1 and loss-of-function mutation in FGFR1 causes Kallmann syndrome through protein-protein interaction with anosmin-1 (12) . The analysis of human genome sequence
has not yet clarified the responsible gene of IHH in the critical region for CES, 22q11. However, future analysis may reveal a novel gene causing IHH through the mechanism of protein-protein interaction with known proteins responsible for IHH. In the present case, serum ALP and bone ALP (markers of osteoblastic activity) were high. A number of reports suggest that androgens influence bone metabolism and hypogona- dism may induce bone loss in men (13) (14) (15) , although the mechanism by which androgen deficiency causes a bone deficit is poorly understood (16) . A previous study reported that bone turnover was increased significantly in men with hypogonadism-induced osteoporosis compared with that in either men with idiopathic osteoporosis or postmenopausal women (17) , which may explain the high levels of serum ALP and bone ALP in the present case. It is unclear whether or not bone turnover related to hypogonadism can be restored to normal after adequate androgen replacement therapy. CES with IHH is extremely rare. Only two cases of CES with IHH have been reported in which cases bisatellited and dicentric marker had been detected (Table 3) . Both subjects had short stature without eunuchoidism [17-year-old male, 157 cm (18), 17-year-old male, 148 cm (19) ]. Although short stature is observed in 36 % of CES (20) , the authors in the latter case concluded that the short stature had been due to malnutrition and mental problems. On the contrary, the present patient had a normal stature (34-year-old male, 176 cm) and typical eunuchoid features. It is reasonable to present eunuchoidism in our case because the patient had no evident problem causing malnutrition and no mental retardation. Furthermore, we speculate that few reports of CES with IHH are due to early death in prepuberty and such patients may be passed over because of various phenotypes of malformation and mental retardation. The present patient was an extremely rare case of CES with isolated IHH. In some cases of CES, intensive endocrinological examinations should be done. 
